Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.
暂无分享,去创建一个
Vandana Sachdev | Mark T Gladwin | M. Gladwin | J. Nichols | R. Machado | Clara C. Chen | V. Sachdev | L. Rubin | Lewis J Rubin | A. Taveira-DaSilva | N. Avila | Roberto F Machado | C. Hunter | A. Anthi | M. Jison | Lori A. Hunter | W. Coles | Anastasia Anthi | Lori Hunter | Nilo A Avila | James Nichols | Christian J Hunter | Maria L Jison | Angelo M Taveira-Dasilva | Wynona Coles | Clara C Chen
[1] Dina Brooks,et al. ATS statement on six-minute walk test. , 2003, American journal of respiratory and critical care medicine.
[2] M. Hartikainen,et al. Mitral valve replacement with ball and tilting disc valve prosthesis. A clinical and haemodynamic study. , 1976, Scandinavian journal of thoracic and cardiovascular surgery.
[3] A. Dwyer,et al. Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies. , 2002, AJR. American journal of roentgenology.
[4] D. Haskard,et al. Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery , 2004, Circulation research.
[5] A. Elami,et al. Impaired oxygenation and increased hemolysis after cardiopulmonary bypass in patients with glucose-6-phosphate dehydrogenase deficiency. , 2003, The Annals of thoracic surgery.
[6] K. Kerr,et al. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. , 1998, American journal of respiratory and critical care medicine.
[7] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[8] Bruce Barton,et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. , 2006, JAMA.
[9] John L. Hankinson,et al. Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[10] B. Zilberstein,et al. Prevalence of pulmonary hypertension in patients with hepatosplenic Mansonic schistosomiasis--prospective study. , 2003, Hepato-gastroenterology.
[11] M. Gladwin,et al. Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension , 2005, British journal of haematology.
[12] M. Gladwin,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[13] Y. Ohara,et al. Hemolytic characteristics of a pivot bearing supported Gyro centrifugal pump (C1E3) simulating various clinical applications. , 1996, Artificial organs.
[14] P. Adegboyega,et al. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. , 2002, Human pathology.
[15] O. Castro,et al. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. , 2003, Blood.
[16] E. Vichinsky. Pulmonary hypertension in sickle cell disease. , 2004, The New England journal of medicine.
[17] J. Krishnan,et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. , 2004, The New England journal of medicine.
[18] D. Farmakis,et al. Cardiac involvement in thalassemia intermedia: a multicenter study. , 2001, Blood.
[19] M. Gladwin,et al. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. , 2005, JAMA.
[20] M. Hughson,et al. Pulmonary thrombotic arteriopathy in patients with sickle cell disease. , 2001, Archives of pathology & laboratory medicine.
[21] R. Dixon,et al. Sitaxsentan therapy for pulmonary arterial hypertension. , 2004, American journal of respiratory and critical care medicine.
[22] J. E. Hansen,et al. Principles of Exercise Testing and Interpretation , 1994 .
[23] G. Grillone,et al. Haemolysis during cardiopulmonary bypass: how to reduce the free haemoglobin by managing the suctioned blood separately , 2001, Perfusion.
[24] J. Hankinson,et al. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). Recommendations for a standard technique--1995 update. , 1995, American journal of respiratory and critical care medicine.
[25] M. Gladwin,et al. Pulmonary Hypertension in Sickle Cell Disease: Cardiopulmonary Evaluation and Response to Chronic Phosphodiesterase 5 Inhibitor Therapy. , 2004 .
[26] E. Strauss,et al. Systemic surgical shunts and splenomegaly as causes of haemolysis in portal hypertension in mansonic schistosomiasis. Evaluation through serum levels of haptoglobin, hemopexin and bilirubins. , 1986, Journal of hepatology.
[27] Arvind K. Shah,et al. Causes of death in sickle cell disease: an autopsy study , 2003, British journal of haematology.
[28] A. Van Tosh,et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. , 1985, Journal of the American College of Cardiology.
[29] Stanley L Hazen,et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. , 2005, JAMA.
[30] J. E. Hansen,et al. Predicted values for clinical exercise testing. , 2015, The American review of respiratory disease.
[31] H. Hellems,et al. Hemodynamic Studies in Sickle Cell Anemia , 1954, Circulation.
[32] L. Olson,et al. Parenchymal scarring is associated with restrictive spirometric defects in patients with chronic thromboembolic pulmonary hypertension. , 1996, Chest.
[33] J. E. Hansen,et al. Pulmonary function in primary pulmonary hypertension. , 2003, Journal of the American College of Cardiology.
[34] Bosentan therapy for pulmonary arterial hypertension. , 2002, The New England journal of medicine.
[35] M. Gladwin,et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. , 2005, Journal of the American College of Cardiology.
[36] W. Travis,et al. Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis. , 2003, American journal of respiratory and critical care medicine.
[37] M. Gladwin,et al. Pulmonary complications of sickle cell anemia. A need for increased recognition, treatment, and research. , 2001, American journal of respiratory and critical care medicine.
[38] S. Roy,et al. Hemodynamic Effects of Chronic Severe Anemia , 1963, Circulation.
[39] Paul Sorajja,et al. Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension. , 2006, Journal of the American College of Cardiology.
[40] G. Venn,et al. A clinical evaluation of platelet function, haemolysis and oxygen transfer during cardiopulmonary bypass comparing the Quantum HF-6700 to the HF-5700 hollow fibre membrane oxygenator , 2000, Perfusion.